NOBIVAC® DHPPi
For the active immunisation of dogs against canine distemper, infectious canine hepatitis, canine parvo virus disease and canine parainfluenza virus infection.
FOR ANIMAL USE ONLY
Nobivac® DHPPi
Lyophilisate and solvent for suspension for injection
Reg. No. G2377 (Act 36/1947)
Namibia Reg. No. V97/24.1/900 [NS2]
Only for use by or under the supervision of persons registered in terms of or authorised in terms of Section 23 (1) (c) of the Veterinary and Para-veterinary Professions Act, 1982 (Act no. 19 of 1982).
Nobivac DHPP vaccines
COMPOSITION
Each 0,5 mℓ vial of the lyophilised substance contains live, attenuated strains of:
- canine distemper virus (CDV) not less than 104 TCID50,
- canine adenovirus type 2 (CAV2) not less than 104 TCID50,
- canine parvovirus (CPV) not less than 107 TCID50 and
- canine parainfluenza virus (CPI) not less than 105,5 TCID50.
Each vial contains a single dose for reconstitution.